The discs in your spine act as shock absorbers, positioned between the blocks of bone called the vertebra. A disc comprises an outer wall of oblique fibres called the Annulus Fibrosus and an inner gel containing protein and water called the Nucleus Pulposus. The discs are flexible, allowing the spine to bend forward (flexion), backwards (extension), sideways (lateral flexion) and rotate.
Cervical total disc replacement (CTDR), or cervical disc arthroplasty, is a surgical procedure to treat certain conditions affecting the cervical spine (neck). It involves replacing a damaged or degenerated disc in the neck with an artificial disc implant.
CTDR is typically considered an alternative to traditional cervical fusion surgery. It aims to preserve the motion and flexibility of the neck while relieving pain and maintaining stability in the cervical spine.
An Artificial Disc is a device that can be implanted into the spine, replacing the damaged disc to permit normal load bearing and motion of the spine.
The Artificial Disc is also called a disc replacement, disc prosthesis or arthroplasty device. Most disc tissue is removed with total disc replacement, and the artificial disc is inserted into the disc space between the vertebrae.
Artificial Discs have two cobalt-chromium metal plates; one is attached to the vertebra above the disc being replaced and the other to the vertebra below. A central core, either metal or plastic (called polyethylene), is between the two plates, permitting motion in the ball and socket principal. The devices allow motion by smooth curved surfaces gliding across each other.
Artificial discs have been used in Europe since the late 1980s and are approved by the FDA in the USA. The devices were used in Australia from the mid-1990s until 2006, when the TGA approval was withdrawn on cervical artificial discs only because of the cost (approximately AUD 9,000 each). Since 2006 cervical artificial discs have not been funded for public or privately insured patients. Funding continues for lumbar artificial discs. Cervical and lumbar artificial discs are available for self-funded or approved Workcover patients.
A Cervical Total Disc Replacement can be used to treat pain arising from a damaged disc, which is compressing the spinal cord or nerve roots which has not responded to non-operative care such as medication, injections, rest and physiotherapy.
The goal of Artificial Disc replacement is to:
Artificial Disc replacement is usually performed in patients under 55 years of age.
Certain conditions prevent a patient from receiving an artificial disc. These include marked loss of disc space height, thin bones (osteoporosis), a slip of one vertebra across another (called spondylolisthesis), vertebral body fracture, spine tumour or infection, significant wear and tear arthritis in the small facet joints at the back of your spine or allergies to the materials in the artificial disc device. In addition, significant surgery to the front (anterior) of your neck or abdomen, previous radiotherapy or morbid obesity may prevent access to insert the artificial disc device into your neck or lumbar spine.
After removing the painful disc and relief of the spinal cord or nerve root compression, the Artificial Disc allows motion at the operated level.
In contrast to fusion, where the vertebrae above and below the damaged disc are fused, the Artificial Disc may reduce the wear and tear risks to discs above and below the operated level.
The Artificial Disc may permit a more rapid return to activities than fusion surgery.
The patient is encouraged to return to gradual progression and normal motion early in the postoperative period.
There are different types of artificial disc implants used in CTDR, including
Mr Malham is credentialed to use the Prestige, Prodisc-C, Mobi-C, Synergy, Maverick and M6 Lumbar prostheses. He has lectured, taught courses and attends regular national & international conferences on Artificial Disc Replacements.
Mr Malham’s preferred prostheses since 2004 are the Prestige and Synergy in the cervical or neck and Maverick with M6 in the lumbar region. This choice is based on the safety, stability (resistance to shear forces) and results these devices provide. All devices are TGA approved in Australia and FDA-approved in the U.S.A.
Mr Malham has no financial arrangement or benefits from using these prostheses.
Tell Mr Malham about any medical conditions or previous operations. Suppose you have a medical condition such as diabetes, heart problems, high blood pressure or asthma. In that case, Mr Malham may arrange for a specialist physician to see you for a pre-operative assessment and medical care following the neurosurgery.
Inform Mr Malham of the medication you are taking and/or have allergies to medications. You must stop using the following ten days pre-operatively:
You must stop using blood thinning medication (such as Warfarin) 3-5 days pre-operatively.
Mr Malham is credentialed to use the Prestige, Prodisc-C, Mobi-C, Synergy, Maverick and M6 Lumbar prostheses. He has lectured, taught courses and attends regular national & international conferences on Artificial Disc Replacements. Mr Malham’s preferred prostheses since 2004 are the Prestige and Synergy in the cervical or neck and Maverick with M6 in the lumbar region. This choice is based on the safety, stability (resistance to sheer forces) and results these devices provide. All devices are TGA approved in Australia and FDA-approved in the U.S.A. Mr Malham has no financial arrangement or benefits from using these prostheses.
During a CTDR procedure, the following steps generally take place:
The Cervical Artificial Disc Replacement improves arm pain, numbness and weakness in 80 - 90% of patients. No change in symptoms occurs in 10%.
Studies have shown that CTDR can improve quality of life, reduce pain, and increase patient satisfaction. However, individual outcomes can vary depending on factors such as the patient's overall health, the severity of the condition, and adherence to post-operative care and rehabilitation.
The total risk of cervical artificial disc replacement is approximately 2%.
Specific risks are infection, bleeding, hoarse voice (dysphonia), problems with swallowing (dysphagia), Horner’s syndrome (small pupil and drooping eyelid), nerve root damage (causing pain, numbness and weakness in the arms), damage to the spinal cord, causing weakness of arms and legs (quadriparesis) or paralysis (quadriplegia), failure of the fusion or movement of the cage.
General risks associated with any surgical procedure are heart attack, pneumonia, blood clots in the legs (DVT), which can travel to the lungs (pulmonary embolism), stroke, drug reaction, general anaesthesia and death.
If CTDR is delayed, the individual may continue to experience symptoms related to their underlying condition, such as neck and arm pain, limited range of motion, and reduced quality of life. Delaying treatment could lead to further degeneration of the affected discs or additional spinal issues. However, the impact of delayed treatment can vary depending on the specific condition and individual circumstances.
Consult with a neurosurgeon to assess the severity of the condition and determine the most appropriate course of action. They can provide personalised guidance on the risks and benefits of CTDR and help decide if delaying the procedure would be advisable or if alternative treatments or interventions may be necessary.
Contact Us
Hours
Monday to Friday
9.00am – 5.00pm
*This may vary on occasions or the rooms may be briefly unattended.
All Rights Reserved | Greg Malham, Neurosurgeon, BSc MBChB DMed FRACS